[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367054-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367054-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identification-and-validation-of-glucose-metabolism-related-gene-signature-in-endometrial-cancer","Identification and validation of glucose metabolism-related gene signature in endometrial cancer","","Metabolic syndrome driven by glucose metabolism is closely linked to tumor development, with endometrial cancer (EC) as a key clinical concern. This study constructed and validated a glucose metabolism-related gene (GMRG) prognostic signature for EC. Differential expression and LASSO plus univariate Cox modeling identified six prognostic genes and generated risk subgroups. Immune profiling, single-cell analysis, and single-gene expression validation used RT-qPCR and immunohistochemistry, with in vitro assays supporting the oncogenic role of SLC38A3.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-and-validation-of-glucose-metabolism-related-gene-signature-in-endometrial-cancer/367054/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-and-validation-of-glucose-metabolism-related-gene-signature-in-endometrial-cancer/367054.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of this study on endometrial cancer?","Question",{"text":63,"@type":64},"To develop and validate a glucose metabolism-related gene (GMRG) prognostic signature linked to endometrial cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the candidate genes and the prognostic signature determined?",{"text":68,"@type":64},"Differentially expressed genes between EC and normal samples from TCGA-EC were intersected with glucose metabolism-related genes, and the final prognostic set was built using LASSO regression and univariate Cox analysis.",{"name":70,"@type":61,"acceptedAnswer":71},"Which biological validation methods were used and what key finding emerged?",{"text":72,"@type":64},"Gene expression was quantified by RT-qPCR and confirmed by immunohistochemistry in clinical samples, and functional relevance of key genes was tested using in vitro assays. SLC38A3 was identified as the key gene and suggested to function as an oncogene in EC.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367054,1790746731,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Jiang et al. BMC Cancer (2025) 25:30 BMC Cancer  \n[https://doi.org/10.1186/s12885-024-13418-9](https://doi.org/10.1186/s12885-024-13418-9)  \nRESEARCH Open Access  \nIdentification and validation of glucose metabolism-related gene signature in endometrial cancer  \nJuan Jiang 1†, Nan Xia2†, Mei Yang3, Ping Qiu 1, Wei Zhu 1, Jing Chen2 and Jiamei Zhu 1,3*  \nAbstract  \nBackground Metabolic syndrome associated with glucose metabolism plays a pivotal role in tumorigenesis, potentially elevating the risk of endometrial cancer (EC) . This study sought to establish a glucose metabolism-related gene (GMRG) signature linked to EC.  \nMethods Differential analysis was conducted to identify differential ly expressed genes (DEGs) between EC and normal samples from theTCGA-EC dataset. Glucose metabolism-related DEGs (GMR-DEGs) were then derived by intersecting these DEGs with GMRGs. A prognostic signature for EC was developed through the Least Absolute Shrinkage and Selection Operator (LASSO) regression and univariate Cox analysis. Additionally, immune profiling and immunotherapy responsiveness were evaluated across two distinct risk subgroups, accompanied by a single-cell analysis of prognostic genes. The expression levels of these prognostic genes were quantified at both transcriptional and translational stages using reverse transcription quantitative PCR (RT-qPCR) and immunohistochemistry (IHC) in clinical samples. Furthermore, the functional significance of key genes was explored through in vitro assays.  \nResults 2,912 DEGs and 202 GMR-DEGs were identified between the EC and normal groups. Subsequently, six prognostic genes were derived, including ASRGL1, SLC38A3, SLC2A1, ALDH1B1, GAD1, and GLYATL1 . EC patients were classified into high and low-risk subgroups based on the six genes. Independent prognostic analysis indicated that risk score and disease stage were significant independent prognostic factors. Single-cell analysis revealed that the six prognostic genes were highly expressed in ciliated and epithelial cells. Immune cell infiltration was generally lower in the high-risk group, where tumor purity was elevated. The expression levels of SLC38A3, SLC2A1, and ASRGL1 are higher in tumor samples by RT-qPCR, with IHC confirming increased SLC38A3 expression. Finally, SLC38A3 may function as oncogenes in EC, as revealed by the results of in vitro experiments.  \nConclusions In this study, we developed six novel prognostic genes in EC based on glycolysis, and corresponding prognostic models were developed. Notably, we identified SLC38A3 as the key gene, which offers valuable insights for further research into EC.  \nKeywords Endometrial cancer, Glucose metabolism, Prognostic signature, Risk subgroups  \n†Juan Jiang and Nan Xia contributed equally to this work.  \n*Correspondence: Jiamei Zhu [15861039098@163.com](15861039098@163.com)  \n1Department of Obstetrics and Gynecology, Jingjiang People’s Hospital Affiliated to Yangzhou University, Taizhou, China  \n2Department of Pathology, Jingjiang People’s Hospital Affiliated to Yangzhou University, Taizhou, China  \n3Advanced Molecular Pathology, Institute of Soochow University and SANO, Suzhou, China  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended us","cbCaislP7rEm4ofU","https://ap.wps.com/l/cbCaislP7rEm4ofU","pdf",12844823,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What was the main goal of this study on endometrial cancer?\",\"answer\":\"To develop and validate a glucose metabolism-related gene (GMRG) prognostic signature linked to endometrial cancer.\"},{\"question\":\"How were the candidate genes and the prognostic signature determined?\",\"answer\":\"Differentially expressed genes between EC and normal samples from TCGA-EC were intersected with glucose metabolism-related genes, and the final prognostic set was built using LASSO regression and univariate Cox analysis.\"},{\"question\":\"Which biological validation methods were used and what key finding emerged?\",\"answer\":\"Gene expression was quantified by RT-qPCR and confirmed by immunohistochemistry in clinical samples, and functional relevance of key genes was tested using in vitro assays. SLC38A3 was identified as the key gene and suggested to function as an oncogene in EC.\"}]","Identification and validation of glucose metabolism-related gene signature in endometrial cancer | PDF",1790169083,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a7e2aa2caa30edec2952cd0fabc8313.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0b91b595fc799d24537b8eaab5a92dd.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca875b9fb5fdb0be31891ae610707911.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/100d62c5f7404b19bad029f383f0248f.webp",980,1306]